Foreground Capital — Full Portfolio

AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US

Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)

BoardSurbhi Sarna(Director)

Co-investorsAlleyCorpGood Growth CapitalJoyance PartnersY CombinatorAstiaAurum Venture Partners+18 more

Bloom Life provides a platform that gives care teams clinical oversight of high-risk patient populations, using customizable clinical protocols and notifications to flag patients needing attention and address potential complications early.

Digital HealthHealthtech

Julien Penders(Founder)inEric Dy(Founder)in

Co-investorsAct One VenturesGATHER VENTURES

Bloomlife provides a remote patient monitoring platform for high-risk patient populations, offering customizable clinical protocols and smart notifications that help care teams identify patients in need and address potential complications early.

Digital HealthFemTechHealthtechSan Francisco, US

Julien Penders(Executive Officer, Director)inEric Dy(Executive Officer, Director)inYoung Sohn(Director)Max Mirgoli(Director)Lucio Lanza(Director)

BoardUriridiakoghene Onovakpuri(Director)

Co-investors15th RockGATHER VENTURESHealthtech CapitalPallasite VenturesSuncoast VenturesThe Chernin Group (TCG Crypto)

Cadence provides over-the-counter contraceptive products including morning-after pills, pregnancy tests, and UTI relief kits distributed through convenience stores.

ConsumerFemTechHealthtech

Samantha Miller 🌱(Founder)in

Co-investorsBuckhill CapitalGratitude Railroad

Providing insurance-covered specialized therapy and community support for perinatal mental health conditions.

Mobilizing the power of the community and technology to deliver personalized, home-based maternity care for underserved communities.

Cirqle is developing a hormone-free, on-demand contraceptive that uses a molecule to reinforce the natural cervical mucus barrier and block sperm.

BiotechDigital HealthFemTech

Frederik Petursson Madsen(Co-founder)

Co-investorsRhia Ventures

Making continuous hormone monitoring possible by bringing the first at-home technology, giving real time insights from the hormones in your saliva.

Cofertility is a fertility company focused on the family-building journey, offering egg freezing, egg donation matching, and related support services to individuals and families.

Digital HealthFemTechHealthtechNew York, US

Lauren Makler(Founder)inHalle Teccoin

Co-investorsCoalition OperatorsEverywhere VenturesHow Women InvestMuse CapitalNext VenturesPress On Ventures+5 more

Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception.

BiotechDigital HealthMedical DevicesCharlottesville, US

Kevin S Eisenfrats(Executive Officer, Director, Promoter)Kevin Eisenfrats(Co-Founder and CEO)John Herr(Co-Founder)

BoardIris Van Alderwerelt van Rosenburgh(Director)Gurdane Bhutani(Director)inMartin J Emerson(Director)

Co-investorsBiotechnology Value FundMBX CapitalAllied Venture PartnersAmboy Street VenturesAurum Venture PartnersBeni Venture Capital+14 more

Eli develops and manufactures at-home hormone level tests that collect longitudinal data on daily hormonal patterns.

AI & Machine LearningConsumerDeep TechDigital HealthFemTechWellness & FitnessMontréal, CA

Thomas Cortina(Founder)in

Co-investors2048 VenturesBDC Thrive Venture Fund for WomenCake VenturesGarage CapitalMuse CapitalPanache Ventures+3 more

Evvy is an AI-powered precision medicine platform using vaginal microbiome testing and analysis to diagnose and treat women's health conditions including vaginal health, fertility, and menopause.

AI & Machine LearningDigital HealthFemTechHealthtech

Priyanka Jain(Founder)inLaine Bruzek(Founder)in

Co-investorsAmboy Street VenturesIngeborg InvestmentsLeft Lane CapitalVirtue VenturesBBG VenturesG9 Ventures+3 more

Co-investorsBuoyant Ventures Management, LlcCRV (Charles River Ventures)Gunung CapitalHarmony PartnersInventureUVC Partners

Developing a non-hormonal treatment for endometriosis to reduce pain and lesion burden.

Co-investorsAmboy Street Ventures

Gesynta Pharma develops pharmaceutical treatments for inflammation and pain by selectively inhibiting the enzyme mPGES-1.

BiotechDigital HealthFemTechStockholm, SE

Patric Stenberg(Founder)Gunilla Ekström(Founder)in

Co-investorsAmboy Street VenturesCatalyze CapitalHadean VenturesHealthCapIndustrifondenXGEN Venture

Vitra develops reproductive therapies that mature eggs outside the body in a controlled environment, aiming to reduce or eliminate the hormone injections required in conventional IVF.

BiotechFemTechHealthtech

Ivana Muncie-Vasic(Founder)in

Co-investorsBreakout VenturesNorth South VenturesSpacecadet VenturesBoom Capital VenturesRefactor Capital

Mae provides community-based doula support and maternal health education for pregnant people, integrating with insurance and Medicaid to match mothers with doulas and care coordinators.

Digital HealthFemTechHealthtechNew York City, US

Maya Hardigan(Founder)

Co-investorsAstiaBright VenturesJoyance PartnersJumpstart NovaSocial StartsSteelSky Ventures+2 more

Millie is a maternity and women's health clinic offering midwifery-led care backed by OB-GYNs and specialists, covering pregnancy, birth, postpartum, gynecology, and hormonal/menopause care.

Digital HealthFemTechHealthtech

Co-investorsAmboy Street VenturesCoyote VenturesIngeborg InvestmentsJoyance PartnersTMVvenn growth partners+2 more

Nadia Care offers maternity support programs that pair members with maternity coaches and a care team for prenatal, labor, feeding, postpartum, nutritional, and mental health support.

Digital HealthFemTechWellness & Fitness

Co-investorsFlare Capital Partners

Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.

BiotechHealthtechMedical DevicesSan Jose, US

Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)Dave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)

Co-investorsCerity Partners VenturesPortfoliaTreo Ventures, LlcWindham Capital PartnersAction Potential Venture Capital Ltd.Vertex Ventures HC

Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.

FemTechHealthtechMedical DevicesMountain View, US

Donald Lee(Executive Officer)Amelia Degenkolb(Executive Officer, Director)

BoardLilly DeSouza Burr(Director)Curt LaBelle(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)

Co-investorsLaerdal Million Lives FundTullis

Nurx provides accessible and affordable medications and tests through a digital health platform designed for everyone.

Digital HealthDirect to ConsumerFemTechHealthtechWellness & FitnessNew York City, US

Edvard Engesaeth(Founder)

Co-investorsComcast VenturesDreamers VCFifty YearsGarage CapitalKleiner PerkinsY Combinator+2 more

OCON Therapeutics develops intrauterine drug-delivery products based on its IUB platform, including a hormone-free IUD contraceptive, an endometrial ablation device for abnormal and heavy menstrual bleeding, and a therapeutic-delivery device targeting conditions such as endometriosis and myomas.

BiotechFemTechMedical Devices

Co-investorsAstiaPontifax Venture Capital

Ovia Health provides digital health tools and clinical programs for reproductive and family health, including fertility, pregnancy, and parenthood support.

Digital HealthFemTechHealthtechWellness & FitnessBoston, US

Alex Baron(Founder)in

Co-investorsBoutique Venture PartnersLightbankLionBirdMartin VenturesTechstars

Raydiant Oximetry is a clinical-stage medical device company developing Lumerah, a noninvasive fetal pulse oximeter that directly measures fetal oxygen levels using biophotonics and machine learning.

Digital HealthFemTechMedical DevicesSan Ramon, US

Michael Nagel(Chief Executive Officer)John Maroney(Director)Charles McDonald(Director)Neil P. Ray(Executive Officer, Director)

Co-investorsBand of AngelsFemHealth VenturesSteelSky VenturesTri-Valley VenturesAvestria VenturesBill & Melinda Gates Foundation+3 more

Seven Starling provides virtual mental healthcare and psychiatric support for women experiencing anxiety, depression, or trauma related to fertility, pregnancy, pregnancy loss, postpartum, early parenthood, and menopause.

Digital HealthFemTechMental Health

Tina Keshani(Founder)inSophia Richter(Founder)in

Co-investorsBand of AngelsDorm RoomDria VenturesExpaGraham Walker VentureMagnify Ventures+5 more

Co-investorsAmboy Street VenturesHelm

Astoria, US

Demetrius Michael Karagas(Executive Officer, Director)Steven Craig Gutentag(Executive Officer, Director)Steven Gutentag(Founder)in

BoardRebecca Kaden(Director)in

Co-investorsComcast VenturesConnetic VenturesCVS Health VenturesEvolution VC PartnersGreycroftHealthQuest Capital+11 more

Twentyeight Health is a telehealth service that lets users complete an online medical questionnaire reviewed by a licensed provider, who writes prescriptions for sexual and reproductive health needs and mails medication directly to patients.

Digital HealthDirect to ConsumerFemTechBrooklyn, US

BRUNO VAN TUYKOM(Executive Officer, Director)Amy Fan(Co-founder)Bruno Van Tuykom(Co-founder)

BoardWES BARTON(Director)ARIANNE KIDDER(Director)in

Co-investorsAglae VenturesData TechDorm RoomFairhaven Capital PartnersImpact America FundPredictive VC+7 more

Redesigning maternity care with holistic, tech-enabled, midwife-led pregnancy care.

San Francisco, US

Ivana Muncie-Vasic(Executive Officer, Director)Bonnie Maven(Director)

BoardJulia Moore(Director)

Women of Wearables (WoW) is a global organization and ecosystem for companies, female innovators, entrepreneurs, and allies working in health technology and femtech, providing community, connections, and knowledge.

Digital HealthFemTechHealthtech

YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.

BiotechFemTechHealthtech

Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)

Co-investorsBlue Bear VenturesCivilization Ventures Management, LlcFuture VenturesNorth South VenturesPortfoliaOlive Tree Capital+1 more

YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.

BiotechHealthtechMedical DevicesSan Francisco, US

Akash Bakshi(Founder)inNadja Mannowetz(Founder)in

Co-investorsBlue Bear VenturesOlive Tree CapitalPortfoliaY Combinator